ETHealthworld.com brings latest atrial fibrillation news, views and updates from all top sources for the Indian Health industry.

Our Lady Of Lourdes Heart Hospital relocated its Electrophysiology Lab, expanding advanced AFib and heart rhythm care for ...

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.

Developments shaping the medtech industry in 2025 offer a glimpse of what may unfold as we head into the new year.

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer tumors to kill them — is emerging as a new option. The FDA recently granted ...

In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and ...

CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (ICCM) (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...

CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...

Introduction Cryoablation technologies have transformed the treatment of paroxysmal atrial fibrillation, with pulmonary vein isolation (PVI) being a key treatment. Technical advancements, including ...